Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies and risk management. We use options pricing models to derive market expectations for stock movement over different time periods and expiration dates. We provide IV analysis, expected move calculations, and volatility surface modeling for comprehensive coverage. Understand option market expectations with our comprehensive IV analysis and move calculation tools for options trading.
As of April 9, 2026, Pasithea Therapeutics Corp. (KTTA) trades at a current price of $0.76, marking a 0.52% decline in the most recent trading session. This analysis evaluates key technical levels, prevailing market context, and potential price action scenarios for the clinical-stage biotech stock, with no recent earnings data available for the company as of the current date. Key points for market observers to monitor include clearly defined near-term support and resistance bands, recent volume
Is Pasithea Therapeutics (KTTA) Stock Good for Passive Investors | Price at $0.76, Down 0.52% - Most Watched Stocks
KTTA - Stock Analysis
4017 Comments
855 Likes
1
Saroun
Daily Reader
2 hours ago
Who else is in the same boat?
👍 52
Reply
2
Javir
Experienced Member
5 hours ago
Useful for both new and experienced investors.
👍 146
Reply
3
Karlisle
Regular Reader
1 day ago
Creativity at its finest.
👍 241
Reply
4
Maleni
Insight Reader
1 day ago
I read this and now I need to think.
👍 99
Reply
5
Senon
Trusted Reader
2 days ago
Anyone else trying to understand this?
👍 207
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.